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Abstract 
People who are incarcerated are likely to meet criteria for at least one substance use disorder 
and need access to treatment. Access to such interventions was limited prior to the COVID-19 
pandemic and has almost certainly been restricted further due to implementation of procedures 
intended to stop the spread of the virus. In this brief commentary, we discuss how COVID-19 
has revealed the already tenuous access that people who are incarcerated have to behavioral 
health services, and the pitfalls of reliance on the U.S. carceral system as a response to 
addiction. 
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1. Introduction
The United States incarcerates more of its citizens than any other country in the world. 
There are approximately 746,000 people in jails and more than 1.2 million in prisons 
(Sawyer and Wagner, 2020)1. System-level behaviors and policies determine who is 
ultimately incarcerated (e.g., policing and enforcement; what is criminalized and how 
severely; Wildeman and Wang, 2017). Racial/ethnic minorities—especially Black men—
are disproportionately incarcerated, as are people with substance use disorders and 
most other mental illnesses (Fazel et al., 2017). Once incarcerated, people are wholly 
reliant on these facilities for their health care needs, including substance use treatment. 
In this COVID-19 special section commentary, we review the intersecting epidemics of 
mass incarceration and addiction, and how the pandemic has highlighted the pitfalls of 
reliance on the carceral system as a response to addiction. We also briefly share our 
experiences as volunteer service providers2 in Arkansas' state prison system—which 
has had recent and nationally unprecedented growth in incarceration—to support this 
assertion. Throughout, we highlight dual realities: the urgent need for mass 
_______________________________________________
This is the author's manuscript of the article published in final edited form as:
Zielinski, M. J., Hinton, K. E., & Bull, C. E. (2021). COVID-19 highlights the pitfalls of reliance on the carceral system as a 
response to addiction. Journal of Substance Abuse Treatment, 122, 108190. https://doi.org/10.1016/j.jsat.2020.108190
decarceration and the urgent need for substance use treatment providers to bring their 
expertise to carceral systems. 
2. Mass incarceration and addiction as intersecting epidemics 
The Bureau of Justice Statistics estimates that 58% of people in prison and 63% of 
people in jail meet diagnostic criteria for a substance use disorder (Bronson et al., 
2017), and more than 85% of incarcerated people are substance-involved (The National 
Center on Addiction and Substance Abuse (CASA), 2010).Yet access to substance use 
treatment in carceral settings is limited in the best of times (Belenko and Peugh, 2005; 
Taxman et al., 2007). About 11% of incarcerated people receive services such as 
counseling or medication, with addiction-focused peer support (23%) and education 
(14%) slightly more common (The National Center on Addiction and Substance Abuse 
(CASA), 2010). Less than 1% of jails and prisons provide medication-assisted treatment 
(Vestal, 2018), despite that it reduces risk of post-release opioid use by 78% (Moore et 
al., 2019). The result is that people with substance use disorders leaving incarceration 
have significantly higher mortality (Chang et al., 2015) and die from opioid overdoses at 
a rate that is 40 times that of their peers in the two weeks postrelease (Ranapurwala et 
al., 2018). 
3. Carceral settings as COVID-19 epicenters 
Since the onset of the COVID-19 pandemic, an already poor situation has gotten worse. 
Incarcerated people with substance use disorders have high rates of medical 
comorbidities that elevate risk for COVID-19 mortality and morbidity (Mukherjee and El-
Bassel, 2020). Typical confinement conditions and overcrowding impede or prohibit 
infection control procedures (Barnert et al., 2020; Henry, 2020) and, as of this writing, 
43 of the 50 largest clusters in the U.S. were within prisons and jails (The New York 
Times, 2020). 
Many experts—including public health professionals, public defenders, and government 
officials—have advocated for mass decarceration to effectively curb the spread of the 
virus nationally (Howell et al., 2020; Ransom and Feuer, 2020; Rich et al., 2020). 
Individual states, counties, and courts have varied widely in their responses to such 
calls, from very little change in most state prison systems to some jails having reduced 
their population by up to 50% (https://www.prisonpolicy.org/virus/virusresponse.html, 
2020). In Arkansas, we have seen similar variability. Our regional jail has reduced their 
census to a level not seen since 20053, but our state prison system has expedited 
releases for comparably few. 
 
 
4. Invisible costs of COVID-19 in carceral settings: implications for addiction 
treatment 
Policies intended to limit the spread of COVID-19 will likely worsen other aspects of 
health and limit already tenuous access to substance use services for people who 
remain incarcerated. For example, to reduce the spread of COVID-19 through carceral 
systems, facilities have eliminated facility access for all but essential staff. Because 
some combination of facility staff, contracted providers, external volunteers, and/or 
peers in recovery (Taxman et al., 2007) offer recovery programming, substance use 
education and treatment almost certainly decreased early in the pandemic. Additionally, 
many facilities are isolating people within single cells or barracks, effectively suspending 
internally facilitated group substance use treatment indefinitely. 4 
Research should assess how the severity of restrictions has affected substance use 
treatment access and the impact of increased isolation due to the pandemic; here, we 
offer our experiences as a lived example. Our university-based team had been offering 
multiple therapeutic groups in one prison as volunteers each Friday for nearly three 
years. Since the pandemic hit, we have had to cease services completely. Our weeks of 
attempts to transition to televideo failed due to a combination of factors, including 
inadequate prison staffing support and new quarantine procedures that limited 
movement within the facility. Even with strong leadership support for innovative ways to 
continue services, we could not overcome barriers that the facility put in place to 
manage an outbreak in an institutional setting. 
5. Conclusions 
While the pandemic is an extreme example of factors that can interrupt addiction 
treatment in carceral settings, it is not the exception. COVID-19 has simply highlighted 
the tenuous access that people who are incarcerated have to behavioral health 
services, and the pitfalls of reliance on the carceral system as a response to addiction. 
At the same time, substance use treatment providers need to engage with carceral 
systems now, more than ever, to avoid seeing rates of postrelease overdose and death 
continue to rise. 
This is a unique moment in history for (re)considering our national policies on crime and 
punishment. It is also a moment that can be leveraged for the public good if those with 
the power to change systems take the opportunity to do so. 
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